1. Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases

   • Elena Perenthaler
   • Anita Nikoncuk
   • Tahsin Stefan Barakat

   Original Paper Open access 09 December 2019 Pages: 415 - 442

   

2. Human subiculo-fornico-mamillary system in Alzheimer’s disease: Tau seeding by the pillar of the fornix

   • Manon Thierry
   • Susana Boluda
   • Charles Duyckaerts

   Original Paper 10 December 2019 Pages: 443 - 461

   

3. Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease

   • Marta J. Koper
   • Evelien Van Schoor
   • Dietmar Rudolf Thal

   Original Paper 04 December 2019 Pages: 463 - 484

   

4. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

   • Charles E. Evans
   • James S. Miners
   • Patrick G. Kehoe

   Original Paper Open access 25 January 2020 Pages: 485 - 502

   

5. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins

   • Grant T. Corbett
   • Zemin Wang
   • Dominic M. Walsh

   Original Paper Open access 18 December 2019 Pages: 503 - 526

   

6. Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions

   • Patricia Aguilar-Calvo
   • Alejandro M. Sevillano
   • Christina J. Sigurdson

   Original Paper 31 October 2019 Pages: 527 - 546

   

7. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns

   • Lidia Stork
   • David Ellenberger
   • Imke Metz

   Original Paper Open access 16 January 2020 Pages: 547 - 564

   

8. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern

   • E. Servián-Morilla
   • M. Cabrera-Serrano
   • Carmen Paradas

   Original Paper 03 January 2020 Pages: 565 - 582

   

9. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker

   • Andrey Korshunov
   • Konstantin Okonechnikov
   • Andreas von Deimling

   Original Paper 28 November 2019 Pages: 583 - 596

   

10. Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker

    • Melike Pekmezci
    • Joanna J. Phillips
    • Arie Perry

    Correspondence 07 January 2020 Pages: 597 - 600

    

11. Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations

    • Jason Chiang
    • Xiaoyu Li
    • David W. Ellison

    Correspondence 10 December 2019 Pages: 601 - 602

    

12. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

    • Daniel J. Brat
    • Kenneth Aldape
    • Michael Weller

    Correspondence 29 January 2020 Pages: 603 - 608